SGMT
Sagimet Biosciences Inc. Series A
9.20$
+1.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +12,300.0% | +8.1% | -3.0% | – | – | – | |
| – | -74.1% | +145.7% | -1.3% | +165.4% | +6.0% | +22.0% | |
| – | -71.2% | – | – | – | – | – | |
| – | -88.4% | -173.3% | – | -123.2% | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | -590.3% | – | |
| – | – | – | – | – | – | – | |
| – | +272.7% | -85.9% | -100.7% | – | +21.6% | -99.7% | |
| – | +639.8% | -120.5% | – | – | -99.1% | -5,923.0% | |
| – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.